Why the study?
HFpEF is the most common cause of pulmonary hypertension, and accurately distinguishing it from pulmonary arterial hypertension has critical treatment implications.
How should pulmonary hypertension be diagnosed and managed in patients at risk for HFpEF?
How should pulmonary hypertension be diagnosed and managed in patients at risk for HFpEF?
Answers are grounded in this paper and cite their sources.
Accurate diagnosis of HFpEF versus pulmonary arterial hypertension using exercise right heart catheterization is critical due to vastly different treatment options.
Heart failure with preserved ejection fraction (HFpEF) is now the most common cause of pulmonary hypertension (PH), and the diagnosis of HFpEF should be considered in any patient with a preserved left ventricular systolic function being evaluated for PH. Accurately diagnosing HFpEF as compared with pulmonary arterial hypertension has critical treatment implications, given the vastly different treatment options available, and can be accurately guided using exercise right heart catheterization. In this review, the diagnostic approach and treatment implications of PH in patients at risk for HFpEF will be discussed.
No takes yet. Share an insight, caveat, or question.
Yogesh N.V. Reddy (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: